MCL1 and breast cancer: They found that the constructed PBP@Cas13a/crMcl-1 nanosystem may suppress Mcl-1 at the transcriptional level, lowering Mcl-1 protein expression and increasing apoptosis in breast cancer cells through in vitro and in vivo tests [117].